Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 16;25(22):5332.
doi: 10.3390/molecules25225332.

Recovery of a Bacteriocin-Like Inhibitory Substance from Lactobacillus bulgaricus FTDC 1211 Using Polyethylene-Glycol Impregnated Amberlite XAD-4 Resins System

Affiliations

Recovery of a Bacteriocin-Like Inhibitory Substance from Lactobacillus bulgaricus FTDC 1211 Using Polyethylene-Glycol Impregnated Amberlite XAD-4 Resins System

Nur Fazrin Husna Abdul Aziz et al. Molecules. .

Abstract

Lactobacillus bulgaricus is a LAB strain which is capable of producing bacteriocin substances to inhibit Staphylococcus aureus. The aim of this study was to purify a bacteriocin-like inhibitory substance (BLIS) produced by L. bulgaricus FTDC 1211 using an aqueous impregnated resins system consisting of polyethylene-glycol (PEG) impregnated on Amberlite XAD4. Important parameters influencing on purification of BLIS, such as the molecular weight and concentration of PEG, the concentration and pH of sodium citrate and the concentration of sodium chloride, were optimized using a response surface methodology. Under optimum conditions of 11% (w/w) of PEG 4000 impregnated Amberlite XAD4 resins and 2% (w/w) of sodium citrate at pH 6, the maximum purification factor (3.26) and recovery yield (82.69% ± 0.06) were obtained. These results demonstrate that AIRS could be used as an alternate purification system in the primary recovery step.

Keywords: bacteriocin-like inhibitory substance; lactic acid bacteria; polymer; purification; resin.

PubMed Disclaimer

Conflict of interest statement

The authors have declared no conflict of interest.

Figures

Figure 1
Figure 1
Antimicrobial activity of (a1) 90% (v/v) of CCFS from L. bulgaricus FTDC1211, (a2,a3) 100% (v/v) of CCFS from L. bulgaricus FTDC1211 in duplicate and (b) control with 15 mg/mL of streptomycin against S. aureus.
Figure 2
Figure 2
The purification factor and recovery yield achieved for different concentration of sodium citrate (A), pH of sodium citrate (B) and NaCl (C). The results reported were expressed as a mean of triplicate reading with an estimated error of ±5%.
Figure 2
Figure 2
The purification factor and recovery yield achieved for different concentration of sodium citrate (A), pH of sodium citrate (B) and NaCl (C). The results reported were expressed as a mean of triplicate reading with an estimated error of ±5%.
Figure 3
Figure 3
3D surface plot for purification factor obtained for the combination effect of (A) concentration of PEG 4000 and pH of sodium citrate, (B) concentration of PEG 4000 and sodium citrate concentration and (C) pH and concentration of sodium citrate.
Figure 4
Figure 4
SDS-PAGE profile. Lane 1: standard marker with molecular weight of 10 to 180 kDa. Lane 2: partially purified BLIS from L. bulgaricus FTDC1211.

References

    1. Morell E.A., Balkin D.M. Methicillin-resistant Staphylococcus aureus: A pervasive pathogen highlights the need for new antimicrobial development. Yale J. Biol. Med. 2010;83:223–233. - PMC - PubMed
    1. Abbasiliasi S., Tan J.S., Ibrahim T.A.T., Ramanan R.N., Vakhshiteh F., Mustafa S., Ling T.C., Rahim R.A., Ariff A.B. Isolation of Pediococcus acidilactici Kp10 with ability to secrete bacteriocin-like inhibitory substance from milk products for applications in food industry. BMC Microbiol. 2012;12:260. doi: 10.1186/1471-2180-12-260. - DOI - PMC - PubMed
    1. Hor Y.Y., Liong M.T. Use of extracellular extracts of lactic acid bacteria and bifidobacteria for the inhibition of dermatological pathogen Staphylococcus aureus. Dermatol. Sin. 2014;32:141–147. doi: 10.1016/j.dsi.2014.03.001. - DOI
    1. Abbasiliasi S., Tan J.S., Ibrahim T.A.T., Kadkhodaei S., Ng H.S., Vakhshiteh F., Ajdari Z., Mustafa S., Ling T.C., Rahim R.A. Primary recovery of a bacteriocin-like inhibitory substance derived from Pediococcus acidilactici Kp10 by an aqueous two-phase system. Food Chem. 2014;151:93–100. doi: 10.1016/j.foodchem.2013.11.019. - DOI - PubMed
    1. Zhang J., Yang Y., Yang H., Bu Y., Yi H., Zhang L., Han X., Ai L. Purification and partial characterization of Bacteriocin Lac-B23, a novel Bacteriocin production by Lactobacillus plantarum J23, isolated from Chinese traditional fermented milk. Front. Microbiol. 2018;9:2165. doi: 10.3389/fmicb.2018.02165. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources